Regeneron Pharmaceuticals, Inc.
Biologically active molecules, conjugates thereof, and therapeutic uses

Last updated:

Abstract:

The present disclosure relates to linker compounds that are useful in covalently linking biologically active molecules with Ligands. The disclosed compounds also relate to biologically active molecules and Ligand conjugates, wherein the biologically active molecule is linked to the Ligand through a linker. The disclosure further provides compositions comprising biologically active molecule-ligand conjugates, methods of modifying abnormal cell growth and methods of treatment using the conjugates or the compositions.

Status:
Grant
Type:

Utility

Filling date:

10 Jan 2020

Issue date:

31 May 2022